ArticleNanomaterials (Basel, Switzerland)2018
Electrospun CuO-Nanoparticles-Modified Polycaprolactone @Polypyrrole Fibers: An Application to Sensing Glucose in Saliva.
Article in Nanomaterials (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 44 citations in OpenAlex.
- Metal oxide-polymer hybrid composites: a comprehensive review on synthesis and multifunctional applications.RSC advances · 2025Review
- Advances in Fiber-Based Wearable Sensors for Personal Digital Health Monitoring.Materials (Basel, Switzerland) · 2023Review
- Advancements in Nanofiber-Based Electrochemical Biosensors for Diagnostic Applications.Biosensors · 2023Review
- A Nanotechnology-Based Approach to Biosensor Application in Current Diabetes Management Practices.Nanomaterials (Basel, Switzerland) · 2023Review
- Recent Advancement in Biofluid-Based Glucose Sensors Using Invasive, Minimally Invasive, and Non-Invasive Technologies: A Review.Nanomaterials (Basel, Switzerland) · 2022Review
- Electrospun nanofiber-based glucose sensors for glucose detection.Frontiers in chemistry · 2022Review
- Electrochemical Sensors Fabricated by Electrospinning Technology: An Overview.Sensors (Basel, Switzerland) · 2019Review
- Poly-ε-Caprolactone/Gelatin Hybrid Electrospun Composite Nanofibrous Mats Containing Ultrasound Assisted Herbal Extract: Antimicrobial and Cell Proliferation Study.Nanomaterials (Basel, Switzerland) · 2019Article
- Shape Memory Polyurethane Biocomposites Based on Toughened Polycaprolactone Promoted by Nano-Chitosan.Nanomaterials (Basel, Switzerland) · 2019Article
- Engineering Surface and Optical Properties of TiO₂-Coated Electrospun PVDF Nanofibers Via Controllable Self-Assembly.Nanomaterials (Basel, Switzerland) · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A non-invasive method for detecting glucose is pursued by millions of diabetic patients to improve their personal management of blood glucose. In this work, a novel CuO nanoparticles (NPs) decorated polycaprolactone@polypyrrole fibers modified indium-tin oxide (denoted as CuO/PCL@PPy/ITO) electrode has been fabricated by electrospinning combined with the electrodeposition method for non-enzymatic detection of glucose in saliva fluid. The electrospun composite fibers exhibit high sensitivity for the glucose detection. The synergistic effect between CuO and PPy together with the unique three-dimensional net structure contributes the reliable selectivity, good test repeatability, large-scale production reproducibility in massive way, the reasonable stability and a high catalytic surface area to the sensor. Quantitative detection of glucose is determined in the linear range from 2 μM to 6 mM and the lowest detection limit is 0.8 μM. The CuO/PCL@PPy/ITO electrode shows potential for the non-invasive detection of salivary glucose.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.